Mahesh Konduru

Mahesh Konduru is currently a Principal at the Potomac Energy Fund. He is an alumnus of the MIT Sloan School of Management.

Energy Subsidies: A Historical Perspective
As we turn the page on the year 2011, there is no shortage of topics about which the entire world seems to be debating. One that interests me the most is... Read more »
Lessons in Energy from an MIT Sloan School Grad
A little less than two years ago I made the decision to enroll at MIT Sloan for an MBA. Shortly after getting to the campus, I made the decision to look... Read more »
Are Government and Utilities the New Sexy Destinations for MBAs?
I’m sure some of you have heard a version of this quote before: “In the 1950s, 60s, and 70s, large families in the U.S. sent their fifth or sixth child to... Read more »
The Summer Internship Shuffle
If you are a student enrolled in a MBA program these days, phrases like “Boy, your timing in going back to school has been perfect!” and/or “This is the best time... Read more »
High-Energy Startups: A Report from the Sloan School Tech Trek
“You should visit us more often!” said one of our hosts during the MIT Sloan School of Management’s Massachusetts Tech Trek two weeks ago. The host’s enthusiasm was understandable—the company had... Read more »

Page 1 of 1

Xconomy Insight

From Our Editors · Special Report
Xcelerating Life Sciences Philadelphia: Special Report
Becoming the Cell & Gene Therapy Hub

Sponsored · Whitepaper
The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
IBM Watson

Sponsored · Whitepaper
Navigating Challenges & Advancing Clinical Development: A Toolkit for Emerging Biotechs
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
Medpace

We offer a number of ways to subscribe for free!